Is a complete HOWL research report available?

No complete published report is available for Werewolf Therapeutics, Inc. (HOWL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Werewolf Therapeutics, Inc. (HOWL)

NASDAQ: HOWL · USD

$0.50

+0.04 (+8.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first HOWL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	24.3M
Net income (ttm)	-56.3M
EPS (ttm)	-$1.23
Shares out	48.6M
Volume	678,454
Beta	0.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -56.3M
EPS (ttm): -$1.23
Market cap: 24.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All HOWL indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001785530
Company name	Werewolf Therapeutics, Inc.
Country	United States
Country code	US
Cusip	95075A107
Employees	14
Employees Change	-25%
Employees Change Percent	-64.1
Enterprise value	$15.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-04-30
Isin	US95075A1079
Last refreshed	2026-07-31
Market cap	$24.3M
Market cap category	Nano-Cap
Price	$0.5
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	HOWL
Website	https://werewolftx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-229.68%
FCF yield	-212.02%
P/B ratio	2.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-33.9M
Net Income	$-56.3M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Profit Per Employee	$-4M
ROA	-39.07
Roa5y	-25.52
ROCE	-286.9
ROE	-161.9
Roe5y	-62.52
ROIC	-44.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-61.53%
Cagr3y	-43.19%
Cagr5y	-50.98%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$58M
Cash	$46.5M
Current Assets	$48.7M
Current Liabilities	$38.5M
Debt	$37.7M
Debt Equity	$3.09
Equity	$12.2M
Interest Coverage	-10.4
Liabilities	$45.8M
Long Term Assets	$9.3M
Long Term Liabilities	$7.3M
Net Cash	$8.8M
Net Cash By Market Cap	$35.92
Net Cash Growth	-84.01%
Net Debt Equity	$-0.72
Tangible Book Value	$12.2M
Tangible Book Value Per Share	$0.25
WACC	9.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Net Working Capital	$-5.8M
Quick ratio	1.21
Working Capital	$10.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-61.51%
200-day SMA	0.75
3Y total return	-81.67%
50-day SMA	0.39
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.17%
All Time High	23.99
All Time High Change	-97.91%
All Time High Date	2021-04-30
All Time Low	0.27
All Time Low Change	85.33%
All Time Low Date	2026-06-29
ATR	0.05
Beta	0.3
Beta1y	1.76
Beta2y	2.06
Ch YTD	-21.01
High	0.54
High52	2.38
High52 Date	2025-09-29
High52ch	-78.97%
Low	0.44
Low52	0.27
Low52 Date	2026-06-29
Low52ch	85.33%
Ma50ch	28.24%
Price vs 200-day SMA	-33.37%
RSI	69.36
RSI Monthly	36.3
RSI Weekly	43.39
Sharpe ratio	-0.48x
Sortino ratio	-0.61
Total Return	-6.4%
Tr YTD	-21.01
Tr1m	62.47%
Tr1w	38.92%
Tr3m	-26.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.31
Operating Income	$-51.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,914,544%
Float Percent	98.6%
Shares Insiders	1.4%
Shares Institutions	21.59%
Shares Out	48,596,817
Shares Qo Q	-1.26%
Shares Yo Y	6.4%
Short Float	1.95%
Short Ratio	0.94
Short Shares	1.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-57.1M
Adjusted OCF	-57,109,000
Average Volume	767,021.15x
Bv Per Share	0.25
Ch1m	62.47
Ch1w	38.92
Ch1y	-61.51
Ch3m	-26.41
Ch3y	-81.67
Ch5y	-97.17
Ch6m	-30.94
Change	8.78%
Change From Open	11.2
Close	0.46
Days Gap	-2.17
Depreciation Amortization	1,606,000
Dollar Volume	339,498.4
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-56M
EBITDA	$-54.4M
EPS	$-1.23
F Score	1
FCF	$-51.9M
FCF EV Yield	-330.86x
FCF Per Share	$-1.07
Financing CF	6,028,000
Fiscal Year End	December
Founded	2,017
Ipr	-96.87
Iprfo	-97.25
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-27
Ma150	0.61
Ma150ch	-17.85%
Ma20	0.38
Ma20ch	30.76%
Net CF	-45,913,000
Next Earnings Date	2026-08-13
Open	0.45
Optionable	Yes
Position In Range	60.52
Post Close	0.5
Postmarket Change Percent	-3.86
Postmarket Price	$0.48
Ppne	9,288,000
Price Date	2026-07-30
Ptbv Ratio	2.01
Relative Volume	0.88x
Share Based Comp	5,168,000
Tr6m	-30.94%
Us State	Massachusetts
Volume	678,454

Werewolf Therapeutics, Inc. (HOWL)

Coverage state: Market snapshot only — no published research

Generate the first HOWL analysis

Price

Financial snapshot

Fair-value bridge

Latest news · HOWL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HOWL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HOWL

Frequently asked questions